Orphan designation: 2'-O-4'-C-(S)-Ethyl-P-thioadenylyl-(3'-O->5'-O)-2'-O-4'-C-(S)-ethyl-P-thioguanylyl-(3'-O->5'-O)-2'-O-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-fluoro-P-thioadenylyl-(3&#

Orphan designation: 2'-O-4'-C-(S)-Ethyl-P-thioadenylyl-(3'-O->5'-O)-2'-O-4'-C-(S)-ethyl-P-thioguanylyl-(3'-O->5'-O)-2'-O-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-fluoro-P-thioadenylyl-(3'-O->5'-O)-2'-fluoro-P-thiocytidylyl-(3'-O->5'-O)-2'-fluoro-P-thiouridylyl-(3'-O->5'-O)-2'-O-methyl-P-thiouridylyl-(3'-O->5'-O)-2'-O-4'-C-(S)-ethyl-P-thiouridylyl-(3'-O->5'-O)-2'-O-4'-C-(S)-ethyl-adenosine Treatment of autosomal dominant polycystic kidney disease, 13/12/2025 Positive

Orphan designation: 4-(4-(2-(Diethylamino)ethoxy)phenyl)-1-(4-methoxybenzyl)-1H-1,2,3-triazol-5-amine Treatment of neurofibromatosis type 2, 13/12/2024 Positive

Orphan designation: 4-(4-(2-(Diethylamino)ethoxy)phenyl)-1-(4-methoxybenzyl)-1H-1,2,3-triazol-5-amine Treatment of neurofibromatosis type 2, 13/12/2024 Positive

Instrument for Pre-accession Assistance (IPA) EMA training on veterinary aspects of AMR and the One Health approach, European Medicines Agency, Amsterdam, the Netherlands, 21 October 2024

Instrument for Pre-accession Assistance (IPA) EMA training on veterinary aspects of AMR and the One Health approach, European Medicines Agency, Amsterdam, the Netherlands, 21 October 2024

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.